Menu Search
Equities

Nakanishi Inc

7716:TYO

Nakanishi Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,329.00
  • Today's Change-180.00 / -7.17%
  • Shares traded668.30k
  • 1 Year change-12.67%
  • Beta0.9448
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform2
Hold2
Sell0
Strong Sell0

Share price forecast in JPY

The 4 analysts offering 12 month price targets for NAKANISHI INC. have a median target of 2,950.00, with a high estimate of 3,500.00 and a low estimate of 2,700.00. The median estimate represents a 26.66% increase from the last price of 2,329.00.
High50.3%3,500.00
Med26.7%2,950.00
Low15.9%2,700.00

Dividends in JPY

In 2023, Nakanishi Inc reported a dividend of 50.00 JPY, which represents a 8.70% increase over last year. The 5 analysts covering the company expect dividends of 52.40 JPY for the upcoming fiscal year, an increase of 4.80%.
Div growth (TTM)8.70%
More ▼

Earnings history & estimates in JPY

NAKANISHI INC. reported annual 2023 earnings of 268.04 per share on Feb 13, 2024.
Average growth rate+39.11%
More ▼

Revenue history & estimates in JPY

Nakanishi Inc. had 3rd quarter 2024 revenues of 18.06m. This missed the 19.41m consensus estimate of the 2 analysts following the company. This was 32.67% above the prior year's 3rd quarter results.
Average growth rate+10.44%
Nakanishi Inc. had revenues for the full year 2023 of 59.69m. This was 22.64% above the prior year's results.
Average growth rate+15.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.